Akers Biosciences Further Expands International Distribution of Flagship Rapid Test
13 avr. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., April 13, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
02 avr. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., April 2, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Biosciences Reports Earnings for Fiscal Year 2014
23 mars 2015 07h00 HE
|
Akers Biosciences Inc.
Revenues Up 24% - Flagship PIFA Heparin/PF4 Rapid Test Sales Double
Conference Call Scheduled for 10:30 a.m. ET Today
THOROFARE, N.J., March 23, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....
Akers Announces Conference Call to Discuss Its Fourth Quarter and Full Year 2014 Earnings
19 mars 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., March 19, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers' Management System Certified to ISO 13485 (2003)
09 févr. 2015 07h03 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Presenting at US Investor Conference
05 févr. 2015 13h06 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers" or the "Company"), a medical device company focused on reducing the cost of healthcare...
European Patent Granted for Akers' Rapid Blood Separation Technology
26 janv. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Expands U.S. Sales Efforts With Key Leadership Additions
20 janv. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Biosciences Signs European Distribution Agreements for PIFA Heparin PF4 Rapid Assay Products
18 déc. 2014 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China
10 déc. 2014 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing...